Gardiquimod

CAS Number

• 1020412-43-4 ^Y
• trifluoroacetate: 1159840-61-5 ^Y

PubChem CID

• 44592366

ChemSpider

• 24665048

UNII

• Y3W4QVW5BY
• trifluoroacetate: 4Y6M4HJ0WU ^Y

Gardiquimod

Identifiers
IUPAC name 1-(4-Amino-2-((ethylamino)methyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol
CAS Number	1020412-43-4 Y trifluoroacetate: 1159840-61-5 Y
PubChem CID	44592366
ChemSpider	24665048
UNII	Y3W4QVW5BY trifluoroacetate: 4Y6M4HJ0WU Y
ChEBI	CHEBI:234430
ChEMBL	ChEMBL1085742
CompTox Dashboard (EPA)	DTXSID801032731
ECHA InfoCard	100.233.311
Chemical and physical data
Formula	C17H23N5O
Molar mass	313.405 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCNCc1nc2c(n1CC(C)(C)O)c3ccccc3nc2N
InChI InChI=1S/C17H23N5O/c1-4-19-9-13-21-14-15(22(13)10-17(2,3)23)11-7-5-6-8-12(11)20-16(14)18/h5-8,19,23H,4,9-10H2,1-3H3,(H2,18,20) Key:FHJATBIERQTCTN-UHFFFAOYSA-N
NY (what is this?)  (verify)

Gardiquimod is an experimental drug which acts selectively at both mouse and human forms of toll-like receptor 7 (TLR7). It functions as an immune response modifier.^[1][2] The core structure is 1H-imidazo[4,5-c]quinoline, as found in related drugs such as imiquimod and resiquimod. It is structurally very similar to resiquimod differing only by an oxygen for nitrogen switch.